![Chris Chapman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Chapman
Corporate Officer/Principal presso Dermavant Sciences Ltd.
Posizioni attive di Chris Chapman
Società | Posizione | Inizio | Fine |
---|---|---|---|
Dermavant Sciences Ltd.
![]() Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 22/01/2020 | - |
Storia della carriera di Chris Chapman
Formazione di Chris Chapman
Towson University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 2 |
Stati Uniti | 2 |
Posizioni
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Dermavant Sciences Ltd.
![]() Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Chris Chapman
- Esperienza